{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:27:58Z","timestamp":1779236878690,"version":"3.51.4"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2020R1A6A1A03041989"],"award-info":[{"award-number":["2020R1A6A1A03041989"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and ICT of Korea","award":["2019R1A2C1007185"],"award-info":[{"award-number":["2019R1A2C1007185"]}]},{"name":"Brain Korea 21 FOUR Project"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Older adults with peripheral arterial disease (PAD) have increased risks of major cardiovascular events and hospitalization. Metabolic comorbidities, such as hypertension, diabetes mellitus, and dyslipidemia, are common risk factors for these unfavorable health events. This study aimed to determine how multiple metabolic comorbidities affect the risk of adverse health outcomes in older adults with PAD. A retrospective cohort study was adopted using administrative claim data from the Health Insurance Review and Assessment Service Agency. The study sample included 3,122 older adults (\u2265 65 years old) with at least one PAD diagnosis in an inpatient setting from 2011 to 2013 and who had at least one follow-up visit after hospitalization by 2018. The three metabolic comorbidities were defined as having at least two diagnostic claims or one prescription per year of anti-hypertensive, anti-diabetic, or anti-dyslipidemic medications for the corresponding diagnosis. The outcome variables included major adverse cardiovascular events (MACEs) and major adverse limb events (MALE). Kaplan-Meier survival curves demonstrated that PAD patients with more metabolic comorbidities had shorter MACE-free and MALE-free periods. Adjusted Cox proportional hazards analyses suggested significant additive effects of multiple metabolic comorbidities on increased risks of MACE and MALE among older adults with PAD. Lower socioeconomic status and non-metabolic comorbidities also increased the risk of MACE. Male sex, being young-old (65\u201374 years), and a higher proportion of inpatient claims increased the risk of MALE. The findings of this study suggest the need for a comprehensive care program for older adults with PAD and metabolic comorbidities. In addition, the healthcare utilization pattern should be considered when designing preventive care for older patients with comorbidities to manage PAD at an earlier stage.<\/jats:p>","DOI":"10.1371\/journal.pone.0268201","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T17:24:47Z","timestamp":1652203487000},"page":"e0268201","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Multiple metabolic comorbidities and their consequences among patients with peripheral arterial disease"],"prefix":"10.1371","volume":"17","author":[{"given":"Young Shin","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi Wook","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-0359","authenticated-orcid":true,"given":"Mona","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"issue":"9901","key":"pone.0268201.ref001","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"FG Fowkes","year":"2013","journal-title":"The Lancet"},{"issue":"3","key":"pone.0268201.ref002","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jvs.2014.03.290","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population","volume":"60","author":"MR Nehler","year":"2014","journal-title":"J Vasc Surg"},{"issue":"6","key":"pone.0268201.ref003","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999\u20132000","volume":"110","author":"E Selvin","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"pone.0268201.ref004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gheart.2013.12.008","article-title":"Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010","volume":"9","author":"UK Sampson","year":"2014","journal-title":"Global heart"},{"issue":"2","key":"pone.0268201.ref005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejvs.2011.09.016","article-title":"Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease","volume":"43","author":"REACH Registry Investigators","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"pone.0268201.ref006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1358863X07084911","article-title":"The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program","volume":"13","author":"JG Regensteiner","year":"2008","journal-title":"Vasc Med"},{"issue":"8","key":"pone.0268201.ref007","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1016\/S0828-282X(10)70437-2","article-title":"One-year costs associated with cardiovascular disease in Canada: insights from the REduction of Atherothrombosis for Continued Health (REACH) registry","volume":"26","author":"KG Smolderen","year":"2010","journal-title":"Can J Cardiol"},{"issue":"1","key":"pone.0268201.ref008","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-9150(03)00204-1","article-title":"High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study","volume":"172","author":"C Diehm","year":"2004","journal-title":"Atherosclerosis"},{"issue":"3","key":"pone.0268201.ref009","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1358863X13489768","article-title":"Apolipoprotein profiles in subjects with and without peripheral artery disease","volume":"18","author":"AW Gardner","year":"2013","journal-title":"Vasc Med"},{"issue":"19","key":"pone.0268201.ref010","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1001\/archinte.160.19.2934","article-title":"Determinants of peripheral arterial disease in the elderly: the Rotterdam study","volume":"160","author":"WT Meijer","year":"2000","journal-title":"Arch Intern Med"},{"issue":"4","key":"pone.0268201.ref011","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/1358863X13493825","article-title":"Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study","volume":"18","author":"SM Grenon","year":"2013","journal-title":"Vasc Med"},{"issue":"1","key":"pone.0268201.ref012","first-page":"1","article-title":"Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study","volume":"19","author":"H Kim","year":"2019","journal-title":"BMC Public Health"},{"issue":"6","key":"pone.0268201.ref013","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/CIRCOUTCOMES.109.930735","article-title":"Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States","volume":"3","author":"EM Mahoney","year":"2010","journal-title":"Cir Cardiovasc Qual Outcomes"},{"key":"pone.0268201.ref014","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2018.09.031","article-title":"Single and combined effects of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events: A prospective cohort study","volume":"279","author":"CH Saely","year":"2018","journal-title":"Atherosclerosis"},{"issue":"10","key":"pone.0268201.ref015","doi-asserted-by":"crossref","first-page":"e110650","DOI":"10.1371\/journal.pone.0110650","article-title":"The incidence and prevalence of diabetes mellitus and related atherosclerotic complications in Korea: a National Health Insurance Database Study","volume":"9","author":"BK Koo","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"pone.0268201.ref016","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3904\/kjim.2018.312","article-title":"Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases","volume":"35","author":"SY Choi","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"26","key":"pone.0268201.ref017","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.3346\/jkms.2019.34.e178","article-title":"Trends in lower limb amputation in patients with diabetic foot based on vascular intervention of peripheral arterial disease in Korea: a population-based nationwide study","volume":"34","author":"J Kim","year":"2019","journal-title":"J Korean Med Sci"},{"issue":"6","key":"pone.0268201.ref018","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4174\/astr.2015.89.6.319","article-title":"National trends for the treatment of peripheral arterial disease in Korea between 2004 and 2013","volume":"89","author":"YY Park","year":"2015","journal-title":"Ann Surg Treat Res"},{"issue":"9426","key":"pone.0268201.ref019","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"S Julius","year":"2004","journal-title":"The Lancet"},{"issue":"2","key":"pone.0268201.ref020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"JN Rasmussen","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"pone.0268201.ref021","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jvs.2017.11.083","article-title":"Epidemiology of lower extremity peripheral artery disease in veterans","volume":"68","author":"J Willey","year":"2018","journal-title":"J Vasc Surg"},{"issue":"9","key":"pone.0268201.ref022","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"MH Criqui","year":"2015","journal-title":"Circ Res"},{"issue":"3","key":"pone.0268201.ref023","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: epidemiology and global perspectives","volume":"14","author":"FG Fowkes","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"pone.0268201.ref024","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/2047487319882154","article-title":"Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: an analysis of the randomized, double-blind COMPASS trial","volume":"27","author":"T Vanassche","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"pone.0268201.ref025","doi-asserted-by":"crossref","first-page":"e007332","DOI":"10.1161\/JAHA.117.007332","article-title":"Frequency of care and mortality following an incident diagnosis of peripheral artery disease in the inpatient or outpatient setting: the aric (atherosclerosis risk in communities) study","volume":"7","author":"CA Kalbaugh","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"pone.0268201.ref026","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jvs.2010.02.003","article-title":"Disparities in vascular surgery: is it biology or environment?","volume":"51","author":"LL Nguyen","year":"2010","journal-title":"J Vasc Surg"},{"issue":"1","key":"pone.0268201.ref027","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jvs.2012.12.031","article-title":"Risk factors for readmission after lower extremity procedures for peripheral artery disease","volume":"58","author":"TR Vogel","year":"2013","journal-title":"J Vasc Surg"},{"issue":"5","key":"pone.0268201.ref028","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.ajkd.2019.08.028","article-title":"Peripheral artery disease: its adverse consequences with and without CKD","volume":"75","author":"M Bourrier","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"pone.0268201.ref029","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jvs.2016.06.096","article-title":"Amputation trends for patients with lower extremity ulcers due to diabetes and peripheral artery disease using statewide data","volume":"64","author":"MD Humphries","year":"2016","journal-title":"J Vasc Surg"},{"issue":"1","key":"pone.0268201.ref030","first-page":"1","article-title":"Sex and gender equity in research: rationale for the SAGER guidelines and recommended use","volume":"1","author":"S Heidari","year":"2016","journal-title":"Res Integr Peer Rev"},{"issue":"4","key":"pone.0268201.ref031","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/01.CIR.88.4.1534","article-title":"Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization","volume":"88","author":"JM Isner","year":"1993","journal-title":"Circulation"},{"issue":"2","key":"pone.0268201.ref032","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jvs.2014.02.059","article-title":"Predictive scoring model of mortality after surgical or endovascular revascularization in patients with critical limb ischemia","volume":"60","author":"T Shiraki","year":"2014","journal-title":"J Vas Surg"},{"issue":"2","key":"pone.0268201.ref033","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40520-017-0760-5","article-title":"Endovascular treatment of diabetic peripheral arterial disease in older and oldest old patients: a retrospective study","volume":"30","author":"C Gatti","year":"2018","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"pone.0268201.ref034","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/dc11-1360","article-title":"Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: US, 1988\u20132008","volume":"35","author":"Y Li","year":"2012","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0268201.ref035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/eurjhf\/hfq185","article-title":"Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?","volume":"13","author":"JA Ezekowitz","year":"2011","journal-title":"Eur J Heart Fail"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T17:25:32Z","timestamp":1652203532000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268201"}},"subtitle":[],"editor":[{"given":"Masaki","family":"Mogi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0268201","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]}}}